Balance Sheet Quest Laboratories Limited

Stocks

QUESTLAB

INE0TNW01017

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:05:09 2026-07-09 EDT			5-day change	1st Jan Change
89.00 ^INR	+1.42%		-5.07%	-19.16%

02-12	Quest Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-12	Quest Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

c0cbde4571b0f9f5.79MGABs6b3SplEeeGl6sCDOnkTOxTp2mQ6Njn6K--_E.hZttaFlKXR_u7AjQVRbpZlzP3neGd8L5es4x3fbprMmNvDdkY3cGI5jtfw

Published financial data: QUEST LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	304M	595M	616M	826M	1.04B
Other Revenues, Total	-	-	-	-	1K
Total Revenues	304M	595M	616M	826M	1.04B
Cost of Goods Sold, Total	246M	446M	419M	523M	806M
Gross Profit	57.86M	149M	197M	302M	233M
Selling General & Admin Expenses, Total	24.1M	32.58M	35.86M	42.84M	43.27M
Depreciation & Amortization - (IS)	3.94M	4.6M	5.5M	5.68M	6.36M
Other Operating Expenses	18.41M	51.26M	81.67M	104M	13.56M
Other Operating Expenses, Total	46.45M	88.44M	123M	152M	63.2M
Operating Income	11.41M	60.43M	73.96M	150M	170M
Interest Expense, Total	-2.86M	-2.65M	-5.2M	-7.27M	-8.43M
Interest And Investment Income	122K	388K	975K	2.29M	25.92M
Net Interest Expenses	-2.73M	-2.27M	-4.22M	-4.98M	17.48M
Other Non Operating Income (Expenses)	-214K	-310K	-187K	-370K	-626K
EBT, Excl. Unusual Items	8.46M	57.85M	69.56M	144M	187M
Gain (Loss) On Sale Of Assets	16.69K	-	40K	-	-
EBT, Incl. Unusual Items	8.48M	57.85M	69.6M	144M	187M
Income Tax Expense	1.93M	16.19M	19.31M	43.52M	51.18M
Earnings From Continuing Operations	6.55M	41.66M	50.28M	101M	136M
Net Income to Company	6.55M	41.66M	50.28M	101M	136M
Net Income - (IS)	6.55M	41.66M	50.28M	101M	136M
Net Income to Common Incl Extra Items	6.55M	41.66M	50.28M	101M	136M
Net Income to Common Excl. Extra Items	6.55M	41.66M	50.28M	101M	136M
Per Share Items
Net EPS - Basic	0.61	3.86	4.66	8.46	8.28
Basic EPS - Continuing Operations	0.61	3.86	4.66	8.46	8.28
Basic Weighted Average Shares Outstanding	10.79M	10.79M	10.79M	11.94M	16.39M
Net EPS - Diluted	0.61	3.86	4.66	8.46	8.28
Diluted EPS - Continuing Operations	0.61	3.86	4.66	8.46	8.28
Diluted Weighted Average Shares Outstanding	10.79M	10.79M	10.79M	11.94M	16.39M
Normalized Basic EPS	0.49	3.35	4.03	7.56	7.13
Normalized Diluted EPS	0.49	3.35	4.03	7.56	7.13
Supplemental Items
EBITDA	15.35M	65.03M	79.46M	155M	176M
EBITA	11.41M	60.43M	73.96M	150M	170M
EBIT	11.41M	60.43M	73.96M	150M	170M
EBITDAR	15.37M	65.15M	79.6M	156M	176M
Total Revenues (As Reported)	304M	595M	619M	828M	1.08B
Effective Tax Rate - (Ratio)	22.79	27.99	27.75	30.13	27.39
Total Current Taxes	1.47M	15.54M	17.92M	42.07M	45.72M
Total Deferred Taxes	458K	651K	1.4M	1.45M	5.46M
Normalized Net Income	5.29M	36.16M	43.47M	90.29M	117M
Interest on Long-Term Debt	-	-	-	2.58K	8.43M
Non-Cash Pension Expense	-	-	220K	20K	-
Supplemental Operating Expense Items
Advertising Expense	5K	5K	41K	81.92K	442K
Selling and Marketing Expenses	5K	5K	41K	81.92K	442K
Net Rental Expense, Total	24.59K	115K	137K	24.59K	60K
Imputed Operating Lease Interest Expense	-	78.94K	158K	31.16K	22.9K
Imputed Operating Lease Depreciation	-	35.65K	-20.73K	-6.57K	37.1K
Maintenance & Repair Expenses, Total	1.24M	1.25M	1.26M	1.02M	699K

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1M	618K	24.97M	1.44M	1.13M
Short Term Investments	-	-	-	-	475M
Trading Asset Securities, Total	-	-	-	-	17.12M
Total Cash And Short Term Investments	1M	618K	24.97M	1.44M	493M
Accounts Receivable, Total	91.55M	221M	199M	234M	300M
Other Receivables	13.22M	15.75M	20.17M	9.17M	7.19M
Notes Receivable	2.79M	1.36M	685K	919K	88K
Total Receivables	108M	238M	220M	244M	308M
Inventory	8.28M	10.87M	112M	161M	214M
Prepaid Expenses	169K	200K	200K	105K	144K
Other Current Assets, Total	1.54M	6.27M	3.61M	9.41M	54.65M
Total Current Assets	119M	256M	361M	416M	1.07B
Gross Property Plant And Equipment	81.49M	100M	131M	140M	162M
Accumulated Depreciation	-22.13M	-26.73M	-32.23M	-37.9M	-43.99M
Net Property Plant And Equipment	59.36M	73.76M	98.39M	102M	118M
Long-term Investments	875K	875K	875K	875K	29.16M
Loans Receivable Long-Term	800K	800K	-	800K	-
Other Long-Term Assets, Total	5.29M	19.23M	6.62M	72.77M	1K
Total Assets	185M	350M	466M	593M	1.22B
Liabilities
Accounts Payable, Total	79.67M	170M	246M	196M	57.29M
Accrued Expenses, Total	5.98M	12.74M	6.74M	8.56M	21.01M
Short-term Borrowings	-	-	-	38.51M	285M
Current Portion of Long-Term Debt	18.86M	17.91M	19.7M	-	4.17M
Current Income Taxes Payable	1.47M	15.54M	14.97M	42.07M	2.82M
Other Current Liabilities	4.37M	15.04M	707K	1.28M	1.64M
Total Current Liabilities	110M	232M	288M	287M	372M
Long-Term Debt	11.54M	13.35M	21.27M	12.3M	13.57M
Pension & Other Post Retirement Benefits	-	-	858K	-	-
Deferred Tax Liability Non Current	4.1M	4.75M	5.98M	7.65M	13.11M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	126M	250M	316M	306M	398M
Common Stock, Total	10.79M	10.79M	10.79M	119M	164M
Additional Paid In Capital	15.98M	15.98M	15.98M	23M	374M
Retained Earnings	32.12M	73.78M	123M	144M	280M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	58.88M	101M	150M	286M	818M
Total Equity	58.88M	101M	150M	286M	818M
Total Liabilities And Equity	185M	350M	466M	593M	1.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.79M	10.79M	10.79M	11.94M	16.39M
ECS Total Common Shares Outstanding	10.79M	10.79M	10.79M	11.94M	16.39M
Book Value / Share	5.46	9.32	13.93	23.99	49.92
Tangible Book Value	58.88M	101M	150M	286M	818M
Tangible Book Value Per Share	5.46	9.32	13.93	23.99	49.92
Total Debt	30.4M	31.25M	40.97M	50.81M	303M
Net Debt	29.4M	30.64M	16M	49.37M	-191M
Debt Equivalent Oper. Leases	197K	917K	1.1M	197K	480K
Account Code - Inventory Valuation	-	5	6	5	5
Inventories - Raw Materials, Total	5.06M	9.85M	111M	161M	172M
Inventories - Work In Process, Total	-	-	-	-	10M
Inventories - Finished Goods, Total	3.22M	1.02M	246K	690K	31.87M
Land - (BS)	1.04M	1.04M	1.04M	1.04M	7.27M
Buildings, Total	40.41M	53.11M	68.19M	73.36M	73.11M
Machinery, Total	40.04M	46.34M	61.39M	65.62M	81.48M
Full Time Employees	-	-	84	74	50

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	6.55M	41.66M	50.28M	101M	136M
Depreciation & Amortization - CF	3.94M	4.6M	5.5M	5.68M	6.36M
Depreciation & Amortization, Total	3.94M	4.6M	5.5M	5.68M	6.36M
(Gain) Loss From Sale Of Asset	-16.69K	257K	-40K	-	-
Other Operating Activities, Total	4.88M	1.15M	8.31M	6.8M	-22.98M
Change In Accounts Receivable	-18.12M	-129M	21.24M	-34.7M	-55.96M
Change In Inventories	34.12M	-2.59M	-101M	-49.66M	-52.46M
Change In Accounts Payable	-15.37M	90.8M	75.55M	-49.92M	-183M
Change in Other Net Operating Assets	838K	24.68M	-23.84M	50.99M	-60.58M
Cash from Operations	16.81M	31.5M	36.31M	30.13M	-233M
Capital Expenditure	-	-19.31M	-30.67M	-9.4M	-34.71M
Sale of Property, Plant, and Equipment	12.07M	55K	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-437M
Other Investing Activities, Total	2.58M	-12.13M	975K	-40.89M	32.35M
Cash from Investing	14.65M	-31.38M	-29.7M	-50.29M	-440M
Short Term Debt Issued, Total	-	-	1.79M	-	247M
Long-Term Debt Issued, Total	477K	-	7.92M	-	4.58M
Total Debt Issued	477K	-	9.72M	-	252M
Long-Term Debt Repaid, Total	-	-	-	-6.47M	-
Total Debt Repaid	-	-	-	-6.47M	-
Issuance of Common Stock	-	-	-	34.5M	432M
Other Financing Activities, Total	-2.95M	-496K	-7.05M	-7.64M	-9.06M
Cash from Financing	-2.47M	-496K	2.67M	20.39M	674M
Miscellaneous Cash Flow Adjustments	-29.3M	-1	-	-	-1.64M
Net Change in Cash	-308K	-385K	9.28M	233K	-307K
Supplemental Items
Cash Interest Paid	3.07M	866K	5.38M	7.64M	9.06M
Cash Income Tax Paid (Refund)	-	15.54M	15.63M	42.07M	40.85M
Levered Free Cash Flow	-	6.19M	-8.2M	-14.23M	-247M
Unlevered Free Cash Flow	-	7.84M	-4.95M	-9.68M	-242M
Change In Net Working Capital	-	15.22M	26M	99.59M	320M
Net Debt Issued / Repaid	477K	-	9.72M	-6.47M	252M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	14.11	11.35	17.63	11.66
Return on Total Capital	-	34.17	28.68	35.38	14.57
Return On Equity %	-	52.26	40.2	46.15	24.56
Return on Common Equity	-	52.26	40.2	46.15	24.56
Margin Analysis
Gross Profit Margin %	19.06	25.03	31.96	36.6	22.43
SG&A Margin	7.94	5.48	5.82	5.19	4.16
EBITDA Margin %	5.06	10.93	12.89	18.83	16.96
EBITA Margin %	3.76	10.16	12	18.14	16.35
EBIT Margin %	3.76	10.16	12	18.14	16.35
Income From Continuing Operations Margin %	2.16	7	8.16	12.23	13.05
Net Income Margin %	2.16	7	8.16	12.23	13.05
Net Avail. For Common Margin %	2.16	7	8.16	12.23	13.05
Normalized Net Income Margin	1.74	6.08	7.05	10.94	11.23
Levered Free Cash Flow Margin	-	1.04	-1.33	-1.72	-23.75
Unlevered Free Cash Flow Margin	-	1.32	-0.8	-1.17	-23.24
Asset Turnover
Asset Turnover	-	2.22	1.51	1.55	1.14
Fixed Assets Turnover	-	8.94	7.16	8.24	9.44
Receivables Turnover (Average Receivables)	-	3.81	2.94	3.81	3.82
Inventory Turnover (Average Inventory)	-	46.57	6.85	3.84	4.3
Short Term Liquidity
Current Ratio	1.07	1.1	1.25	1.45	2.88
Quick Ratio	0.96	1.02	0.85	0.85	2.15
Operating Cash Flow to Current Liabilities	0.15	0.14	0.13	0.11	-0.63
Days Sales Outstanding (Average Receivables)	-	95.77	124.35	96.08	95.62
Days Outstanding Inventory (Average Inventory)	-	7.84	53.28	95.37	84.84
Average Days Payable Outstanding	-	101.77	146.14	141.17	56
Cash Conversion Cycle (Average Days)	-	1.84	31.49	50.27	124.47
Long Term Solvency
Total Debt/Equity	51.63	31.08	27.27	17.74	36.99
Total Debt / Total Capital	34.05	23.71	21.43	15.07	27
LT Debt/Equity	19.6	13.28	14.16	4.29	1.66
Long-Term Debt / Total Capital	12.93	10.13	11.12	3.65	1.21
Total Liabilities / Total Assets	68.15	71.3	67.8	51.69	32.75
EBIT / Interest Expense	3.99	22.76	14.23	20.61	20.16
EBITDA / Interest Expense	5.37	24.5	15.29	21.39	20.92
(EBITDA - Capex) / Interest Expense	5.37	17.22	9.39	20.1	16.8
Total Debt / EBITDA	1.98	0.48	0.52	0.33	1.72
Net Debt / EBITDA	1.92	0.47	0.2	0.32	-1.08
Total Debt / (EBITDA - Capex)	1.98	0.68	0.84	0.35	2.14
Net Debt / (EBITDA - Capex)	1.92	0.67	0.33	0.34	-1.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	95.91	3.63	33.94	25.92
Gross Profit, 1 Yr. Growth %	-	157.28	32.52	53.25	-19
EBITDA, 1 Yr. Growth %	-	323.67	22.06	95.13	13.3
EBITA, 1 Yr. Growth %	-	429.53	22.25	101.94	13.35
EBIT, 1 Yr. Growth %	-	429.53	22.25	101.94	13.35
Earnings From Cont. Operations, 1 Yr. Growth %	-	536.37	22.5	100.08	34.4
Net Income, 1 Yr. Growth %	-	536.37	22.5	100.08	34.4
Normalized Net Income, 1 Yr. Growth %	-	583.61	20.08	107.03	29.34
Diluted EPS Before Extra, 1 Yr. Growth %	-	536.37	22.5	80.83	34.4
Accounts Receivable, 1 Yr. Growth %	-	140.99	-9.63	17.41	22.86
Inventory, 1 Yr. Growth %	-	31.31	926.23	44.51	32.53
Net Property, Plant and Equip., 1 Yr. Growth %	-	24.24	33.41	3.78	15.12
Total Assets, 1 Yr. Growth %	-	89.5	34.05	26.31	100.95
Tangible Book Value, 1 Yr. Growth %	-	70.75	50.31	89.7	185.35
Common Equity, 1 Yr. Growth %	-	70.75	50.31	89.7	185.35
Cash From Operations, 1 Yr. Growth %	-	87.34	5.08	-22.33	-874.08
Capital Expenditures, 1 Yr. Growth %	-	-	58.86	-68.81	269.33
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-232.21	87.95	1.08K
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-162.6	119.72	1.37K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	42.52	17.81	29.87
Gross Profit, 2 Yr. CAGR %	-	-	84.7	42.57	8.75
EBITDA, 2 Yr. CAGR %	-	-	133.79	54.54	48.76
EBITA, 2 Yr. CAGR %	-	-	164.16	57.36	51.37
EBIT, 2 Yr. CAGR %	-	-	164.16	57.36	51.37
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	177.08	56.81	63.99
Net Income, 2 Yr. CAGR %	-	-	177.08	56.81	63.99
Normalized Net Income, 2 Yr. CAGR %	-	-	197.14	57.92	63.64
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	177.08	49.07	33.06
Accounts Receivable, 2 Yr. CAGR %	-	-	47.58	3.01	22.73
Inventory, 2 Yr. CAGR %	-	-	267.08	285.09	38.39
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	28.74	17.67	9.45
Total Assets, 2 Yr. CAGR %	-	-	59.24	30.53	60.98
Tangible Book Value, 2 Yr. CAGR %	-	-	59.72	69.3	132.76
Common Equity, 2 Yr. CAGR %	-	-	59.72	69.3	132.76
Cash From Operations, 2 Yr. CAGR %	-	-	86.2	-6.61	145.21
Capital Expenditures, 2 Yr. CAGR %	-	-	59.41	-30.23	7.32
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	51.48	471.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	10.67	640.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	39.58	20.46
Gross Profit, 3 Yr. CAGR %	-	-	-	73.49	16.19
EBITDA, 3 Yr. CAGR %	-	-	-	116.37	39.4
EBITA, 3 Yr. CAGR %	-	-	-	135.9	41.11
EBIT, 3 Yr. CAGR %	-	-	-	135.9	41.11
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	148.89	48.95
Net Income, 3 Yr. CAGR %	-	-	-	148.89	48.95
Normalized Net Income, 3 Yr. CAGR %	-	-	-	157.48	47.75
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	140.63	29.58
Accounts Receivable, 3 Yr. CAGR %	-	-	-	36.74	10.83
Inventory, 3 Yr. CAGR %	-	-	-	169.03	169.87
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	19.82	16.92
Total Assets, 3 Yr. CAGR %	-	-	-	47.47	51.77
Tangible Book Value, 3 Yr. CAGR %	-	-	-	69.44	101.53
Common Equity, 3 Yr. CAGR %	-	-	-	69.44	101.53
Cash From Operations, 3 Yr. CAGR %	-	-	-	21.47	89
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-7.99	21.6
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	69.91	241.48
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	105.57	212.65
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	31.56
Gross Profit, 5 Yr. CAGR %	-	-	-	-	39.89
EBITDA, 5 Yr. CAGR %	-	-	-	-	75.36
EBITA, 5 Yr. CAGR %	-	-	-	-	88.14
EBIT, 5 Yr. CAGR %	-	-	-	-	88.14
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	116.35
Net Income, 5 Yr. CAGR %	-	-	-	-	116.35
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	113.71
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	99.04
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	32.54
Inventory, 5 Yr. CAGR %	-	-	-	-	38.19
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	17.84
Total Assets, 5 Yr. CAGR %	-	-	-	-	44.75
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	73.3
Common Equity, 5 Yr. CAGR %	-	-	-	-	73.3
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	81.43
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	36.53